Projected Income Statement: Vetoquinol SA

Forecast Balance Sheet: Vetoquinol SA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -53.6 -76.3 -130 -185 -206 -272 -325 -384
Change - -42.35% -70.38% -42.31% -11.35% -32.17% -19.49% -18.15%
Announcement Date 24/03/22 23/03/23 20/03/24 20/03/25 27/03/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Vetoquinol SA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 13.82 16.97 14.9 14.54 17.02 22.9 23.47 22.33
Change - 22.8% -12.23% -2.36% 17.03% 34.53% 2.47% -4.83%
Free Cash Flow (FCF) 1 75.9 45.88 89 71.28 55.05 71.9 63.9 70.83
Change - -39.54% 93.97% -19.91% -22.76% 30.6% -11.13% 10.85%
Announcement Date 24/03/22 23/03/23 20/03/24 20/03/25 27/03/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Vetoquinol SA

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 22.89% 21.85% 21.35% 19.34% 21.67% 21.04% 21.2% 21.64%
EBIT Margin (%) 16.63% 15.67% 13.53% 14.11% 14.99% 14.86% 15.61% 16.07%
EBT Margin (%) 16.59% 13.46% 14.53% 15.02% 15.27% 19.36% 19.6% 20.03%
Net margin (%) 12.07% 8.89% 10.5% 10.89% 10.92% 10.72% 10.76% 11.05%
FCF margin (%) 14.56% 8.5% 16.81% 13.22% 10.47% 13.78% 11.6% 12.23%
FCF / Net Income (%) 120.66% 95.59% 160.07% 121.43% 95.91% 128.51% 107.76% 110.68%

Profitability

        
ROA - 8.24% 8.27% 8.17% 7.61% 6.4% 6.3% 6.6%
ROE 15.46% 10.37% 10.98% 10.64% 9.83% 8.75% 9.28% 8.7%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 2.65% 3.14% 2.81% 2.7% 3.24% 4.39% 4.26% 3.86%
CAPEX / EBITDA (%) 11.58% 14.38% 13.18% 13.95% 14.94% 20.86% 20.09% 17.82%
CAPEX / FCF (%) 18.21% 36.99% 16.74% 20.41% 30.92% 31.85% 36.72% 31.53%

Items per share

        
Cash flow per share 1 7.582 5.312 7.555 7.276 6.202 8.046 8.566 9.283
Change - -29.93% 42.21% -3.69% -14.77% 29.74% 6.46% 8.37%
Dividend per Share 1 0.8 0.8 0.85 0.89 0.93 0.925 1.06 1.113
Change - 0% 6.25% 4.71% 4.49% -0.54% 14.59% 5.03%
Book Value Per Share 1 37.3 40.96 44.54 48.82 50.88 56.95 61.4 66.35
Change - 9.79% 8.75% 9.61% 4.23% 11.92% 7.81% 8.06%
EPS 1 5.33 4.06 4.7 4.98 4.94 4.735 5.353 5.849
Change - -23.83% 15.76% 5.96% -0.8% -4.15% 13.05% 9.27%
Nbr of stocks (in thousands) 11,826 11,829 11,832 11,833 11,796 11,622 11,622 11,622
Announcement Date 24/03/22 23/03/23 20/03/24 20/03/25 27/03/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 14.5x 12.8x
PBR 1.2x 1.12x
EV / Sales 1.01x 0.86x
Yield 1.35% 1.55%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
68.60EUR
Average target price
90.38EUR
Spread / Average Target
+31.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VETO Stock
  4. Financials Vetoquinol SA
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!